Government-sponsored vaccines for the third world
February 13, 2006
Under an advance market commitment plan, the G-8 nations would promise
to subsidize the purchase of new vaccines — for between $800 million
and $6 billion — if pharmaceuticals companies develop ones that meet
standards of efficacy and safety. Once the G-8 spends the pledged
amount, the drug companies would sell the vaccine at a set discount in
the developing world.